MENU

INTS Intensity Therapeutics Inc. Forecast, Technical & Fundamental Analysis

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation... Show more

INTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
INTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

INTS is expected to report earnings to fall 13.96% to -95 cents per share on November 17

Intensity Therapeutics Inc. INTS Stock Earnings Reports
Q3'26
Est.
$-0.95
Q2'26
Missed
by $0.24
Q1'26
Missed
by $0.90
Q4'25
Missed
by $1.26
Q3'25
Est.
$-0.06
The last earnings report on August 11 showed earnings per share of -111 cents, missing the estimate of -87 cents. With 10.73K shares outstanding, the current market capitalization sits at 11.92M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
16
Web
https://www.intensitytherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TANH14.790.91
+6.56%
Tantech Holdings Ltd.
HNVR25.640.41
+1.63%
Hanover Bancorp
MCS27.06-0.05
-0.18%
Marcus Corp (The)
BOX34.49-0.11
-0.32%
BOX
AMP490.91-3.91
-0.79%
Ameriprise Financial

INTS and Stocks

Correlation & Price change

A.I.dvisor tells us that INTS and ACAD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTS and ACAD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTS
1D Price
Change %
INTS100%
-4.75%
ACAD - INTS
28%
Poorly correlated
-1.29%
ASBP - INTS
27%
Poorly correlated
-2.75%
CCCC - INTS
27%
Poorly correlated
-5.71%
IMVT - INTS
27%
Poorly correlated
-0.38%
ADXN - INTS
26%
Poorly correlated
+7.97%
More
Intensity Therapeutics (INTS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com